Tag:
inVentiv Health
Latest Headlines
Latest Headlines
Moody's eyes investor backlash for InVentiv after CRO acquisitions
Moody's Investors Service, a division of the Moody's Corporation, downgraded the ratings outlook for InVentiv from stable to negative.
inVentiv grabs Kforce's clinical research staff biz for $50M
It may not be surprising that Kforce is selling its whole clinical research staffing division to inVentiv Health for $50 million in cash.
PE fund commits $1.1B to inVentiv buyout
The stock market might be iffy about healthcare reform's short-term effects on drugmakers, but a private equity firm has just placed a $1.1 billion bet that a pharmaceutical services firm will thrive
